Topiramate for smoking cessation and the importance to distinguish withdrawal-motivated consumption and cue-triggered automatisms.
Khazaal
Yasser
Y
Zullino
Daniele Fabio
DF
D002248:Carbon Monoxide / Q000378:metabolism; D003463:Cues; D005632:Fructose / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012907:Smoking / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods*; D000074606:Smoking Prevention; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D000077236:Topiramate
D018696:Neuroprotective Agents; D000077236:Topiramate; D005632:Fructose; D002248:Carbon Monoxide